[Thalidomide in the treatment of discoid lupus erythematosus (D.L.E.) (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D055598:Chemical Phenomena; D002621:Chemistry; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents; D007918:Leprosy / Q000188:drug therapy; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013723:Teratogens; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D013723:Teratogens; D013792:Thalidomide
La thalidomide dans le traitement du lupus érythémateux chronoque (L.E.C.).